Retargeting of human T lymphocytes to EGFR-expressing cancer cells via nanobody-based target modules using the universal chimeric antigen receptor technology

Albert, S.; Bergmann, R.; Koristka, S.; Feldmann, A.; Arndt, C.; Aliperta, R.; Ehninger, A.; Cartellieri, M.; Ehninger, G.; Steinbach, J.; Bachmann, M.

Retargeting of human T lymphocytes to EGFR-expressing cancer cells via nanobody-based target modules using the universal chimeric antigen receptor technology

Albert, S.; Bergmann, R.; Koristka, S.; Feldmann, A.; Arndt, C.; Aliperta, R.; Ehninger, A.; Cartellieri, M.; Ehninger, G.; Steinbach, J.; Bachmann, M.

Keywords: CAR T cell therapy; nanobodies; EGFR-targeting

Lecture (Conference)
47th Annual Meeting of the German Society for Immunology, 12.09.2017, Erlangen, Germany

Permalink: https://www.hzdr.de/publications/Publ-26056
Publ.-Id: 26056